The Global AI in Oncology For Analytical Solutions Market is set to soar from USD 1.09 billion in 2024 to USD 8.86 billion by 2035, at a CAGR of 21%. AI is transforming cancer care by enabling faster, more precise diagnostics, predictive therapy selection, and improved patient outcomes. Early adopters are positioned to capture market leadership and significant ROI across clinical, pharma, and payer ecosystems.